Back to 
UBS Group AG
UBS Group AG
SXTC
Showing 0 of 5 quarters
Position history for UBS Group AG's holdings in China SXT Pharmaceuticals, Inc.
No. UBS Group exited its SXTC (China SXT Pharmaceuticals) position in Q2 2022. Its Q1 2022 13F listed 51,812 shares worth $15,000. UBS Group first reported SXTC in Q1 2021 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.